Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 198 of the 202 references it cites were found in a registry or an index; 4 of the 31 sources its claims cite were checked for support.
Abstract
Objective The aim is to provide guidelines for the evaluation and management of adults with hypoglycemic disorders, including those with diabetes mellitus. Evidence Using the recommendations of the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system, the quality of evidence is graded very low (plus sign in circle ooo), low (plus sign in circle plus sign in circle oo), moderate (plus sign in circle plus sign in circle plus sign in circle o), or high (plus sign in circle plus sign in circle plus sign in circle plus sign in circle). Conclusions We recommend evaluation and management of hypoglycemia only in patients in whom Whipple's triad--symptoms, signs, or both consistent with hypoglycemia, a low plasma glucose concentration, and resolution of those symptoms or signs after the plasma glucose concentration is raised--is documented. In patients with hypoglycemia without diabetes mellitus, we recommend the following strategy. First, pursue clinical clues to potential hypoglycemic etiologies--drugs, critical illnesses, hormone deficiencies, nonislet cell tumors. In the absence of these causes, the differential diagnosis narrows to accidental, surreptitious, or even malicious hypoglycemia or endogenous hyperinsulinism. In patients suspected of having endogenous hyperinsulinism, measure plasma glucose, insulin, C-peptide, proinsulin, beta-hydroxybutyrate, and circulating oral hypoglycemic agents during an episode of hypoglycemia and measure insulin ant…
Overview
CoChat Summary
TL;DR
This Endocrine Society clinical practice guideline, developed using the GRADE system, provides recommendations for evaluating and managing hypoglycemic disorders in adults with and without diabetes. It emphasizes documenting Whipple's triad before initiating any workup and frames treatment-induced hypoglycemia as the limiting factor in diabetes glycemic management.
Key findings
- Hypoglycemia should be evaluated and managed only when Whipple's triad is documented (symptoms/signs consistent with hypoglycemia, a low plasma glucose, and resolution after glucose is raised) (1QQQQ).
- In seemingly well patients, endogenous hyperinsulinism is documented by glucose <55 mg/dl (3.0 mmol/liter) with insulin ≥3.0 U/ml (18 pmol/liter), C-peptide ≥0.6 ng/ml (0.2 nmol/liter), and proinsulin ≥5.0 pmol/liter; β-hydroxybutyrate ≤2.7 mmol/liter and a glucose rise ≥25 mg/dl (1.4 mmol/liter) after iv glucagon indicate insulin (or IGF) mediation.
- Insulinoma incidence is approximately 1 in 250,000 patient-years; recurrence after resection is 7% without MEN-1 and 21% with MEN-1. CT detects 70–80%, MRI about 85%, and endoscopic ultrasound in some centers >90%.
- In diabetes, defective glucose counterregulation increases severe hypoglycemia risk 25-fold or more, and hypoglycemia unawareness confers a 6-fold increased risk. In the ACCORD trial, 5.0% of intensive-therapy vs 4.0% of standard-therapy patients died (HR 1.22; 95% CI 1.01–1.46; P=0.04). The UK Hypoglycemia Study reported severe hypoglycemia prevalence of 7% and 25% and incidence of 10 and 70 episodes per 100 patient-years in T2DM patients on insulin for <2 vs >5 years.
Methods
- Guideline development by a Task Force using the GRADE system, with strong recommendations phrased "we recommend" (1) and weak recommendations "we suggest" (2); evidence quality graded QEEE (very low) to QQQQ (high).
- Recommendations cover workup of hypoglycemia, evaluation/management in persons without diabetes, and evaluation/management in persons with diabetes, each linked to Evidence, Values, and Remarks sections.
- Evidence base includes clinical observations, randomized trials (e.g., ACCORD, DCCT, UKPDS), and population-based studies; suggested protocols for a prolonged diagnostic fast (up to 72 h) and a 5-h mixed-meal test are provided.
Limitations
- Stated: because hypoglycemic disorders are rare in persons without diabetes, recommendations for their evaluation and management rely largely on clinical experience, and much lower quality evidence supports the recommended strategy compared with strategies with minor modifications or omissions.
- Stated: standards for interpreting the mixed-meal test have not been established, so fasting criteria are applied to mixed-meal results; the dose-response relationship and time course of oral carbohydrate treatment of hypoglycemia cannot be stated with confidence.
- Stated: reported hypoglycemia event rates in diabetes are generally underestimates due to difficulty of ascertainment, and compelling evidence that continuous glucose sensing reliably helps patients prevent hypoglycemia is still needed. Evident from the text: this 2008 guideline predates several therapies and technologies discussed as emerging.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 0 Not valid · 8 Not checked · 13 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Treatment-induced hypoglycemia is the limiting factor in the glycemic management of diabetes (12,16,84).”
§ Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline > Background
What the sources say
- Not matchedcites [12] 12. Cryer P 2008 Glucose homeostasis and hypoglycemia. In: Kronenberg H, Melmed S, Polonsky K, Larsen P, eds. Williams textbook of endocrinology, 11th ed. Philadelphia: Saunders, an imprint of Elsevier, Inc.; 1503-1533
We searched by its title and found no matching paper.
- Not checked — no full text of the sourcecites [16] 16. Cryer PE 2004 Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350:2272-2279 source
- Supportedcites [84] Cryer, 2002, Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes., Diabetologia source
The Perspective (p. 10) explicitly states that iatrogenic hypoglycaemia remains the limiting factor in the glycaemic management of diabetes. “Iatrogenic” matches the claim’s “treatment-induced.” (LLM, conf=0.95)
- Not matched
Every source the paper cites for this claim was checked and supports it.
In the paper
“The ADA Workgroup on Hypoglycemia recommended that persons with drug-treated diabetes become concerned about developing hypoglycemia at a plasma glucose concentration of 70 mg/dl (3.9 mmol/liter) or less (136).”
§ Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline > 3.1 Evidence
What the sources say
- Supportedcites [136] Diabetes Care source
The Workgroup defines both documented symptomatic and asymptomatic hypoglycemia at a measured plasma glucose concentration of 70 mg/dl (3.9 mmol/l) or less. In “Asymptomatic hypoglycemia” (page unavailable), it describes that cutoff as a conservative lower limit for people with diabetes, supporting the cited advice to be concerned at that level. (LLM, conf=0.88)
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The concept of hypoglycemia-associated autonomic failure (HAAF) in diabetes is based on pivotal findings in nondiabetic individuals (97) and patients with T1DM (101) and was first documented in T1DM (89).”
§ Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline > TABLE 4. Suggested protocol for a prolonged diagnostic fast
What the sources say
- Not checked — no full text of the sourcecites [97] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans., Diabetes source
- Not checked — no full text of the sourcecites [101] Davis, 1992, Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM., Diabetes source
- Partly supportedcites [89] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia., J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says the study’s data document that recent antecedent hypoglycemia can induce HAAF in patients with insulin-dependent diabetes mellitus (type 1 diabetes). The paper does not establish that this was the first documentation of HAAF in that population. (LLM, conf=0.78)
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Drugs are the most common cause of hypoglycemia (12, 18 -21).”
§ Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline > General differential diagnosis
What the sources say
- Not matchedcites [12] 12. Cryer P 2008 Glucose homeostasis and hypoglycemia. In: Kronenberg H, Melmed S, Polonsky K, Larsen P, eds. Williams textbook of endocrinology, 11th ed. Philadelphia: Saunders, an imprint of Elsevier, Inc.; 1503-1533
We searched by its title and found no matching paper.
- Not checked — no full text of the sourcecites [18] 18. Fischer KF, Lees JA, Newman JH 1986 Hypoglycemia in hospitalized pa- tients. Causes and outcomes. N Engl J Med 315:1245-1250 source
- Not checked — no full text of the sourcecites [19] 19. Malouf R, Brust JC 1985 Hypoglycemia: causes, neurological manifesta- tions, and outcome. Ann Neurol 17:421-430 source
- Not checked — no full text of the sourcecites [20] 20. Marks V, Teale JD 1999 Drug-induced hypoglycemia. Endocrinol Metab Clin North Am 28:555-577 source
- Partly supportedcites [21] 21. Park-Wyllie LY, Juurlink DN, Kopp A, Shah BR, Stukel TA, Stumpo C, Dresser L, Low DE, Mamdani MM 2006 Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 354:1352-1361 sourceExperimental — accuracy not yet measured
The Hypoglycemia results (page unavailable) associate recent gatifloxacin treatment with a higher risk of hypoglycemia in older adults. The paper does not compare drugs with other causes of hypoglycemia, so it does not establish that drugs are the most common cause. (LLM, conf=0.84)
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We recommend that both the conventional risk factors and those indicative of compromised defenses against hypoglycemia be considered in a patient with recurrent treatment-induced hypoglycemia (1QQQQ).”
§ Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline > 3.4
20 more claims
Create a free account to see all 25 claims and every source verdict.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recurrent PG levels in this range may result in the development of HAAF, which increases the risk of subsequent hypoglycemia and attenuates its recognition.7,36”
From Recommendations from the Pediatric Endocrine Society for evaluation and management of persistent hypoglycemia in neonates, infants, and children (2015) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the setting of exogenous insulin use and normal pancreatic function, endogenous insulin secretion is suppressed, as evidenced by low c-peptide and pro-insulin.”
From Non-Diabetic Hypoglycemia: Evaluation and Management in Adults (2025) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mixed meal tolerance test (MMTT) is generally considered to be a valid diagnostic tool [12, 43].”
From Spontaneous hypoglycemia: should we mind the gap? Long-term follow-up of healthy people who met Whipple’s triad criteria (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thresholds such as <70 mg/dL are commonly used in practice, although more stringent cutoff values (e.g., <54 mg/dL) are considered for defining clinically significant episodes [6,10].”
From Defining and Characterizing Postprandial Reactive Hypoglycemia (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As a result, clinical practice guidelines for adult hypoglycemic disorders developed by the Endocrine Society do not support the use of the OGTT for diagnosing postprandial hypoglycemia (39).”
From Dumping syndrome after esophageal, gastric or bariatric surgery: Pathophysiology, diagnosis, and management (2017) · cites this paper as [39]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline > Evaluation of hypoglycemia in seemingly well individuals
“plasma C-peptide levels are usually 0.6 ng/ml (0.2 mmol/liter) or greater”
§ Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline > Evaluation of hypoglycemia in seemingly well individuals
“plasma Cpeptide concentrations of at least 0.6 ng/ml (0.2 nmol/liter)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline > Evaluation of hypoglycemia in seemingly well individuals
“plasma C-peptide levels are usually 0.6 ng/ml (0.2 mmol/liter) or greater”
§ Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline > Abstract
“C-peptide of at least 0.6 ng/ml (0.2 nmol/liter)”
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Management of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
Self-citationDefining and Reporting Hypoglycemia in Diabetes
American Diabetes Association Workgroup on Hypoglycemia (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1245 · Cited by 1,146
Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study.
SERVICE, F. J., McMAHON, M. M., O'BRIEN, P. C., & BALLARD, D. J. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62083-7 · Cited by 883
Self-citationRisk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration
UK Hypoglycaemia Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0599-y · Cited by 825
Bolen, S., Feldman, L., Vassy, J., Wilson, L., Yeh, H.-C., Marinopoulos, S., Wiley, C., Selvin, E., Wilson, R., Bass, E. B., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-6-200709180-00178 · Cited by 823
Gold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794
Self-citationHyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
Service, G. J., Thompson, G. B., Service, F. J., Andrews, J. C., Collazo-Clavell, M. L., & Lloyd, R. V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043690 · Cited by 779
Self-citationHypoglycemia in the Diabetes Control and Complications Trial
The Diabetes Control and Complications Trial Research Group (1997) · Diabetes · doi:10.2337/diab.46.2.271 · Cited by 746
Steffes, M. W., Sibley, S., Jackson, M., & Thomas, W. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.832 · Cited by 695
Gerich, J. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1973) · Science · doi:10.1126/science.182.4108.171 · Cited by 688
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Self-citationHirsch, I. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040832 · Cited by 667
Frequency of Severe Hypoglycemia Requiring Emergency Treatment in Type 1 and Type 2 Diabetes
Leese, G. P., Wang, J., Broomhall, J., Kelly, P., Marsden, A., Morrison, W., Frier, B. M., Morris, A. D., & For the DARTS/MEMO Collaboration (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1176 · Cited by 559
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Heller, S. R., & Cryer, P. E. (1991) · Diabetes · doi:10.2337/diab.40.2.223 · Cited by 531
Self-citationDonnelly, L. A., Morris, A. D., Frier, B. M., Ellis, J. D., Donnan, P. T., Durrant, R., Band, M. M., Reekie, G., & Leese, G. P. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01501.x · Cited by 511
Service, F. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504273321707 · Cited by 503
Self-citationFeasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes
Steil, G. M., Rebrin, K., Darwin, C., Hariri, F., & Saad, M. F. (2006) · Diabetes · doi:10.2337/db06-0419 · Cited by 473
Dagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471
Self-citationStettler, C., Allemann, S., Jüni, P., Cull, C. A., Holman, R. R., Egger, M., Krähenbühl, S., & Diem, P. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.09.015 · Cited by 467
Continuous glucose monitoring and closed‐loop systems
Hovorka, R. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01672.x · Cited by 443
Yki-Järvinen, H., Ryysy, L., Nikkilä, K., Tulokas, T., Vanamo, R., & Heikkilä, M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-5-199903020-00002 · Cited by 433
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
Bolli, G., Feo, P. D., Compagnucci, P., Cartechini, M. G., Angeletti, G., Santeusanio, F., Brunetti, P., & Gerich, J. E. (1983) · Diabetes · doi:10.2337/diab.32.2.134 · Cited by 433
Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes.
Cranston, I., Lomas, J., Amiel, S. A., Maran, A., & Macdonald, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91336-6 · Cited by 430
Laing, S. P., Swerdlow, A. J., Slater, S. D., Botha, J. L., Burden, A. C., Waugh, N. R., Smith, A. W. M., Hill, R. D., Bingley, P. J., Patterson, C. C., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00075.x · Cited by 425
Suh, S. W., Gum, E. T., Hamby, A. M., Chan, P. H., & Swanson, R. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30077 · Cited by 419
Diverse causes of hypoglycemia-associated autonomic failure in diabetes.
Cryer, P. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031354 · Cited by 411
Self-citationMechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes
Cryer, P. E. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3592 · Cited by 401
Self-citationFanelli, C. G., Epifano, L., Rambotti, A. M., Pampanelli, S., Di Vincenzo, A., Modarelli, F., Lepore, M., Annibale, B., Ciofetta, M., Bottini, P., et al. (1993) · Diabetes · doi:10.2337/diab.42.11.1683 · Cited by 398
Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.
Amiel, S. A., Sherwin, R. S., Simonson, D. C., & Tamborlane, W. V. (1988) · Diabetes · doi:10.2337/diab.37.7.901 · Cited by 393
White, N. H., Skor, D. A., Cryer, P. E., Levandoski, L. A., Bier, D. M., & Santiago, J. V. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303033080903 · Cited by 391
Self-citation(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-3-199802010-00001 · Cited by 385
Goldfine, A. B., Mun, E. C., Devine, E., Bernier, R., Baz-Hecht, M., Jones, D. B., Schneider, B. E., Holst, J. J., & Patti, M. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0918 · Cited by 377
Pedersen‐Bjergaard, U., Pramming, S., Heller, S. R., Wallace, T. M., Rasmussen, Å. K., Jørgensen, H. V., Matthews, D. R., Hougaard, P., & Thorsteinsson, B. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.482 · Cited by 371
Self-citationOutpatient gatifloxacin therapy and dysglycemia in older adults.
Park-Wyllie, L. Y., Juurlink, D. N., Kopp, A., Shah, B. R., Stukel, T. A., Stumpo, C., Dresser, L., Low, D. E., & Mamdani, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055191 · Cited by 367
Horvath, K., Jeitler, K., Berghold, A., Ebrahim, S. H., Gratzer, T. W., Plank, J., Kaiser, T., Pieber, T. R., & Siebenhofer, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005613.pub3 · Cited by 366
Patti, M. E., McMahon, G., Mun, E. C., Bitton, A., Holst, J. J., Goldsmith, J., Hanto, D. W., Callery, M., Arky, R., Nose, V., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1933-x · Cited by 365
Hypoglycemia, functional brain failure, and brain death.
Cryer, P. E. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31669 · Cited by 363
Self-citationAbraira, C., Colwell, J. A., Nuttall, F. Q., Sawin, C. T., Nagel, N. J., Comstock, J. P., Emanuele, N. V., Levin, S. R., Henderson, W., Lee, H. S., et al. (1995) · Diabetes Care · doi:10.2337/diacare.18.8.1113 · Cited by 355
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Segel, S. A., Paramore, D. S., & Cryer, P. E. (2002) · Diabetes · doi:10.2337/diabetes.51.3.724 · Cited by 337
Self-citationReversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.
Dagogo-Jack, S., Rattarasarn, C., & Cryer, P. E. (1994) · Diabetes · doi:10.2337/diab.43.12.1426 · Cited by 328
Self-citationInsulinomas: localization with selective intraarterial injection of calcium.
Doppman, J. L., Miller, D. L., Chang, R., Shawker, T. H., Gorden, P., & Norton, J. A. (1991) · Radiology · doi:10.1148/radiology.178.1.1984311 · Cited by 318
Unexplained Deaths of Type 1 Diabetic Patients
Tattersall, R. B., & Gill, G. V. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01516.x · Cited by 309
Hypoglycemia in Hospitalized Patients
Fischer, K. F., Lees, J. A., & Newman, J. H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152002 · Cited by 309
A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events
Gangji, A. S., Cukierman, T., Gerstein, H. C., Goldsmith, C. H., & Clase, C. M. (2007) · Diabetes Care · doi:10.2337/dc06-1789 · Cited by 308
Laing, S. P., Swerdlow, A. J., Slater, S. D., Botha, J. L., Burden, A. C., Waugh, N. R., Smith, A. W. M., Hill, R. D., Bingley, P. J., Patterson, C. C., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00076.x · Cited by 304
Swiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302
Self-citationDecreased Epinephrine Responses to Hypoglycemia during Sleep
Jones, T. W., Porter, P., Sherwin, R. S., Davis, E. A., O'Leary, P., Frazer, F., Byrne, G., Stick, S., & Tamborlane, W. V. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382303 · Cited by 301
Service, F. J., Dale, A. J. D., Elveback, L. R., & JIANG, N.-S. (1976) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)07100-9 · Cited by 288
Self-citationHypoglycaemia in insulin‐treated Type 2 diabetes: frequency, symptoms and impaired awareness
Henderson, J. N., Allen, K. V., Deary, I. J., & Frier, B. M. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01072.x · Cited by 287
Hypoglycemia: causes, neurological manifestations, and outcome.
Malouf, R., & Brust, J. C. M. (1985) · Annals of Neurology · doi:10.1002/ana.410170502 · Cited by 286
Maternal Glycemic Control and Hypoglycemia in Type 1 Diabetic Pregnancy
Mathiesen, E. R., Kinsley, B., Amiel, S. A., Heller, S., McCance, D., Duran, S., Bellaire, S., Raben, A., & on behalf of the Insulin Aspart Pregnancy Study Group (2007) · Diabetes Care · doi:10.2337/dc06-1887 · Cited by 265
Self-citationMechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia
Robinson, R. T. C. E., Harris, N. D., Ireland, R. H., Lee, S., Newman, C., & Heller, S. R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1469 · Cited by 264
Self-citationBoyle, P. J., Schwartz, N. S., Shah, S. D., Clutter, W. E., & Cryer, P. E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182302 · Cited by 258
Self-citationTowler, D. A., Havlin, C. E., Craft, S., & Cryer, P. (1993) · Diabetes · doi:10.2337/diab.42.12.1791 · Cited by 258
Self-citationFrequency and Morbidity of Severe Hypoglycaemia in Insulin‐treated Diabetic Patients
MacLeod, K. M., Hepburn, D. A., & Frier, B. M. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb00051.x · Cited by 251
Meier, J. J., Butler, A. E., Galasso, R., & Butler, P. C. (2006) · Diabetes Care · doi:10.2337/dc06-0392 · Cited by 249
(1976) · PubMed · Cited by 244
Self-citationSämann, A., Mühlhauser, I., Bender, R., Kloos, C., & Müller, U. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1905-1 · Cited by 226
ARIOGLU, E., ANDEWELT, A., DIABO, C., BELL, M., TAYLOR, S. I., & GORDEN, P. (2002) · Medicine · doi:10.1097/00005792-200203000-00001 · Cited by 223
Drug-Induced Hypoglycemia: A Systematic Review
Murad, M. H., Coto-Yglesias, F., Wang, A. T., Sheidaee, N., Mullan, R. J., Elamin, M. B., Erwin, P. J., & Montori, V. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1416 · Cited by 222
Self-citationReversibility of unawareness of hypoglycemia in patients with insulinomas.
Mitrakou, A., Fanelli, C., Veneman, T., Perriello, G., Calderone, S., Platanisiotis, D., Rambotti, A., Raptis, S., Brunetti, P., Cryer, P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309163291203 · Cited by 221
Self-citationNikfarjam, M., Warshaw, A. L., Axelrod, L., Deshpande, V., Thayer, S. P., Ferrone, C. R., & Fernández-del Castillo, C. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31815792ed · Cited by 221
Self-citationFatourechi, M. M., Kudva, Y. C., Murad, M. H., Elamin, M. B., Tabini, C. C., & Montori, V. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1415 · Cited by 221
Self-citationImaging and localization of islet-cell tumours of the pancreas on CT and MRI.
Noone, T. C., Hosey, J., Firat, Z., & Semelka, R. C. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.013 · Cited by 217
Fanelli, C., Pampanelli, S., Epifano, L., Rambotti, A. M., Di Vincenzo, A., Modarelli, F., Ciofetta, M., Lepore, M., Annibale, B., Torlone, E., et al. (1994) · Diabetologia · doi:10.1007/bf00399801 · Cited by 212
Kilpatrick, E. S., Rigby, A. S., Goode, K., & Atkin, S. L. (2007) · Diabetologia · doi:10.1007/s00125-007-0820-z · Cited by 209
Hypoglycemia in Pregnant Women With Type 1 Diabetes
Nielsen, L. R., Pedersen-Bjergaard, U., Thorsteinsson, B., Johansen, M., Damm, P., & Mathiesen, E. R. (2008) · Diabetes Care · doi:10.2337/dc07-1066 · Cited by 204
Service, F. J., Natt, N., Thompson, G. B., Grant, C. S., van Heerden, J. A., Andrews, J. C., Lorenz, E., Terzic, A., & Lloyd, R. V. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5645 · Cited by 196
Self-citationSleep-Related Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes
Banarer, S., & Cryer, P. E. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1195 · Cited by 187
Self-citationClinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia.
Fukuda, I., Hizuka, N., Ishikawa, Y., Yasumoto, K., Murakami, Y., Sata, A., Morita, J., Kurimoto, M., Okubo, Y., & Takano, K. (2006) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2006.05.003 · Cited by 186
Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans
Davis, S. N., Shavers, C., Mosqueda-Garcia, R., & Costa, F. (1997) · Diabetes · doi:10.2337/diab.46.8.1328 · Cited by 183
Service, F. J., & Natt, N. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6934 · Cited by 168
Self-citationAnlauf, M., Wieben, D., Perren, A., Sipos, B., Komminoth, P., Raffel, A., Kruse, M. L., Fottner, C., Knoefel, W. T., Mönig, H., et al. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000151617.14598.ae · Cited by 167
Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences
ter Braak, E. W. M. T., Evers, I. M., Willem Erkelens, D., & Visser, G. H. A. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.271 · Cited by 166
Endoscopic ultrasound in the localisation of pancreatic islet cell tumours.
McLean, A. M., & Fairclough, P. D. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.012 · Cited by 163
Service, F. J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1582 · Cited by 163
Self-citationQaseem, A., Vijan, S., Snow, V., Cross, J. T., Weiss, K. B., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-6-200709180-00012 · Cited by 157
Raju, B., & Cryer, P. E. (2005) · Diabetes · doi:10.2337/diabetes.54.3.757 · Cited by 155
Self-citationSaudek, C. D. (1996) · JAMA · doi:10.1001/jama.276.16.1322 · Cited by 154
Wright, A. D., Cull, C. A., Macleod, K. M., & Holman, R. R. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.08.010 · Cited by 153
Vezzosi, D., Bennet, A., Fauvel, J., & Caron, P. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0109 · Cited by 152
Kauhanen, S., Seppänen, M., Minn, H., Gullichsen, R., Salonen, A., Alanen, K., Parkkola, R., Solin, O., Bergman, J., Sane, T., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1479 · Cited by 152
Evers, I. M., ter Braak, E. W. M. T., de Valk, H. W., van der Schoot, B., Janssen, N., & Visser, G. H. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.554 · Cited by 152
Marks, V., & Teale, J. D. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70088-8 · Cited by 150
A review of human and analogue insulin trials
Gough, S. C. L. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.10.015 · Cited by 148
Reichard, P., & Pihl, M. (1994) · Diabetes · doi:10.2337/diab.43.2.313 · Cited by 147
Fukuda, M., Tanaka, A., Tahara, Y., Ikegami, H., Yamamoto, Y., Kumahara, Y., & Shima, K. (1988) · Diabetes · doi:10.2337/diab.37.1.81 · Cited by 145
Scarlett, J. A., Mako, M. E., Rubenstein, A. H., Blix, P. M., Goldman, J., Horwitz, D. L., Tager, H., Jaspan, J. B., Stjernholm, M. R., & Olefsky, J. M. (1977) · New England Journal of Medicine · doi:10.1056/nejm197711102971903 · Cited by 142
Forearm Glucose Uptake During the Oral Glucose Tolerance Test in Normal Subjects
Jackson, R. A., Peters, N., Advani, U., Perry, G., Rogers, J., Brough, W. H., & Pilkington, T. R. E. (1973) · Diabetes · doi:10.2337/diab.22.6.442 · Cited by 139
Hirsch, I. B., Armstrong, D., Bergenstal, R. M., Buckingham, B., Childs, B. P., Clarke, W. L., Peters, A., & Wolpert, H. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0016 · Cited by 136
Continuous Glucose Monitoring in Children with Type 1 Diabetes
⁎ (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.03.047 · Cited by 132
Akram, K., Pedersen‐Bjergaard, U., Carstensen, B., Borch‐Johnsen, K., & Thorsteinsson, B. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01880.x · Cited by 130
Højlund, K., Hansen, T., Lajer, M., Henriksen, J. E., Levin, K., Lindholm, J., Pedersen, O., & Beck-Nielsen, H. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1592 · Cited by 130
DeRosa, M. A., & Cryer, P. E. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00539.2003 · Cited by 126
Self-citationOctreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses.
Boyle, P. J., Justice, K., Krentz, A. J., Nagy, R. J., & Schade, D. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445035 · Cited by 125
A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus.
Bolli, G. B., Feo, P. D., Cosmo, S. D., Perriello, G., Ventura, M. M., Benedetti, M. M., Santeusanio, F., Gerich, J. E., & Brunetti, P. (1984) · Diabetes · doi:10.2337/diab.33.8.732 · Cited by 124
Noninsulinoma pancreatogenous hypoglycemia syndrome: An update in 10 surgically treated patients
Thompson, G. B., Service, F. J., Andrews, J. C., Lloyd, R. V., Natt, N., van Heerden, J. A., & Grant, C. S. (2000) · Surgery · doi:10.1067/msy.2000.110243 · Cited by 121
Self-citationClinical Characterisation of Severe Hypoglycaemia
Holstein, A., Plaschke, A., & Egberts, E.-H. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-42728 · Cited by 119
Boden, G., Reichard, G. A., Hoeldtke, R. D., Rezvani, I., & Owen, O. E. (1981) · New England Journal of Medicine · doi:10.1056/nejm198111123052007 · Cited by 118
Mühlhauser, I., Overmann, H., Bender, R., Bott, U., & Berger, M. (1998) · Diabetologia · doi:10.1007/s001250051065 · Cited by 117
de Heer, J., & Holst, J. J. (2007) · Diabetes · doi:10.2337/db06-0738 · Cited by 115
Witteles, R. M. (2001) · Archives of Surgery · doi:10.1001/archsurg.136.6.656 · Cited by 110
Won, J. G. S., Tseng, H., Yang, A., Tang, K., Jap, T., Lee, C. H., Lin, H., Burcus, N., Pittenger, G., & Vinik, A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02629.x · Cited by 109
Brown, C. K., Bartlett, D. L., Doppman, J. L., Gorden, P., Libutti, S. K., Fraker, D. L., Shawker, T. H., Skarulis, M. C., & Alexander, H. R. (1997) · Surgery · doi:10.1016/s0039-6060(97)90226-9 · Cited by 108
Adult diffuse nesidioblastosis: genetically or environmentally induced?
Klöppel, G., Anlauf, M., Raffel, A., Perren, A., & Knoefel, W. T. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.09.010 · Cited by 108
Bottini, P., Boschetti, E., Pampanelli, S., Ciofetta, M., Sindaco, P. D., Scionti, L., Brunetti, P., & Bolli, G. B. (1997) · Diabetes · doi:10.2337/diab.46.5.814 · Cited by 107
Risk Factors for Frequent and Severe Hypoglycemia in Type 1 Diabetes
Allen, C., LeCaire, T., Palta, M., Daniels, K., Meredith, M., D’Alessio, D. J., & for the Wisconsin Diabetes Registry Project (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1878 · Cited by 106
GRUNBERGER, G., WEINER, J. L., SILVERMAN, R., TAYLOR, S., & GORDEN, P. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-2-252 · Cited by 105
Surgical therapy of hyperinsulinism
Hirner, A., Haring, R., Karavias, T., & Stallkamp, B. (1981) · World Journal of Surgery · doi:10.1007/bf01657953 · Cited by 103
Glucoregulation during and after exercise in health and insulin-dependent diabetes.
Camacho, R. C., Galassetti, P. R., Davis, S. N., & Wasserman, D. H. (2005) · PubMed · Cited by 101
Defective awakening response to nocturnal hypoglycemia in patients with type 1 diabetes mellitus
Schultes, B., Jauch-Chara, K., Gais, S., Hallschmid, M., Reiprich, E., Kern, W., Oltmanns, K. M., Peters, A., Fehm, H. L., & Born, J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040069 · Cited by 100
Alanine and terbutaline in treatment of hypoglycemia in IDDM.
Wiethop, B. V., & Cryer, P. E. (1993) · Diabetes Care · doi:10.2337/diacare.16.8.1131 · Cited by 99
Self-citationMechanisms of sympathoadrenal failure and hypoglycemia in diabetes
Cryer, P. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28735 · Cited by 99
Self-citationEffect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release
Amiel, S. A., Sherwin, R. S., Simonson, D. C., et al. (1988) · Diabetes · doi:10.2337/diabetes.37.7.901 · Cited by 99
Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM.
Davis, M. R., Mellman, M., & Shamoon, H. (1992) · Diabetes · doi:10.2337/diab.41.10.1335 · Cited by 98
Meyer, C., Grossmann, R., Mitrakou, A., Mahler, R., Veneman, T., Gerich, J., & Bretzel, R. G. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1960 · Cited by 95
Nuclear medicine in the detection and management of pancreatic islet-cell tumours.
Virgolini, I., Traub-Weidinger, T., & Decristoforo, C. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.09.001 · Cited by 93
Wiesli, P., Brändle, M., Schmid, C., Krähenbühl, L., Furrer, J., Keller, U., Spinas, G. A., & Pfammatter, T. (2004) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000140638.55375.1e · Cited by 93
Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments
Raju, B., Arbelaez, A. M., Breckenridge, S. M., & Cryer, P. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2798 · Cited by 93
Self-citationClassification of hypoglycemic disorders.
Service, F. J. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70085-2 · Cited by 92
Self-citationGolicki, D., Golicka, D., Groele, L., & Pańkowska, E. (2007) · Diabetologia · doi:10.1007/s00125-007-0884-9 · Cited by 90
Jackson, J. E. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.10.002 · Cited by 89
Murphy, N. P., Ford-Adams, M. E., Ong, K. K., Harris, N. D., Keane, S. M., Davies, C., Ireland, R. H., MacDonald, I. A., Knight, E. J., Edge, J. A., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1552-y · Cited by 88
Self-citationImaging of neuroendocrine tumors: accuracy of helical CT versus SRS.
Kumbasar, B., Kamel, I. R., Tekes, A., Eng, J., Fishman, E. K., & Wahl, R. L. (2004) · Abdominal Imaging · doi:10.1007/s00261-003-0162-3 · Cited by 84
Influence of Autonomic Neuropathy on QTc Interval Lengthening During Hypoglycemia in Type 1 Diabetes
Lee, S. P., Yeoh, L., Harris, N. D., Davies, C. M., Robinson, R. T., Leathard, A., Newman, C., Macdonald, I. A., & Heller, S. R. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1535 · Cited by 84
Self-citationKar, P., Price, P., Sawers, S., Bhattacharya, S., Reznek, R. H., & Grossman, A. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1430 · Cited by 79
Self-citationStandards of Medical Care in Diabetes — 2009: American Diabetes Association
Cunha-Vaz, J. (2010) · Diabetic Retinopathy · doi:10.1142/9789814304443_0001 · Cited by 78
Oral Glucose Tolerance Test Compared With a Mixed Meal in the Diagnosis of Reactive Hypoglycemia
Hogan, M. J., Service, F. J., Sharbrough, F. W., & Gerich, J. E. (1983) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)18811-3 · Cited by 77
Self-citationFactitious hyperinsulinism leading to pancreatectomy: severe forms of Munchausen syndrome by proxy
Giurgea, I., Ulinski, T., Touati, G., Sempoux, C., Mochel, F., Brunelle, F., Saudubray, J.-M., Fekete, C., & de Lonlay, P. (2005) · Pediatrics · doi:10.1542/peds.2004-2331 · Cited by 76
Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix.
Seckl, M. J., Mulholland, P. J., Bishop, A. E., Teale, J. D., Hales, C. N., Glaser, M., Watkins, S., & Seckl, J. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411004 · Cited by 75
Rizza, R. A., Haymond, M. W., Verdonk, C. A., Mandarino, L. J., Miles, J. M., Service, F. J., & Gerich, J. E. (1981) · Diabetes · doi:10.2337/diab.30.5.377 · Cited by 74
Self-citationHypoglycemia: factitious and felonious.
Marks, V., & Teale, J. D. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70089-x · Cited by 70
Guettier, J.-M., & Gorden, P. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.09.005 · Cited by 68
(1983) · PubMed · Cited by 66
Self-citationInsulin autoimmunity and hypoglycemia in seven white patients.
Basu, A., Service, F. J., Yu, L., Heser, D., Ferries, L. M., & Eisenbarth, G. (2005) · Endocrine Practice · doi:10.4158/ep.11.2.97 · Cited by 66
Self-citationReal-time continuous glucose monitoring
Buckingham, B., Caswell, K., & Wilson, D. M. (2007) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32825a675e · Cited by 64
Nauck, M. A., Reinecke, M., Perren, A., Frystyk, J., Berishvili, G., Zwimpfer, C., Figge, A. M., Flyvbjerg, A., Lankisch, P. G., Blum, W. F., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2573 · Cited by 63
Incretin Hypersecretion in Post-Gastric Bypass Hypoglycemia—Primary Problem or Red Herring?
Vella, A., & Service, F. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2260 · Cited by 63
Self-citationDeiss, D., Hartmann, R., Schmidt, J., & Kordonouri, O. (2006) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2006-923887 · Cited by 62
Survey of hospital systems and common serious medication errors.
Cohen, M. R., Proulx, S. M., & Crawford, S. Y. (1998) · Journal of Healthcare Risk Management · doi:10.1002/jhrm.5600180104 · Cited by 60
Kinsley, B. T., Weinger, K., Bajaj, M., Levy, C. J., Simonson, D. C., Quigley, M., Cox, D. J., & Jacobson, A. M. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1022 · Cited by 59
Rickels, M. R., Schutta, M. H., Mueller, R., Kapoor, S., Markmann, J. F., Naji, A., & Teff, K. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2426 · Cited by 59
Unexpected hypoglycemia in a critically ill patient.
Bates, D. W. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-2-200207160-00009 · Cited by 58
Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism.
Kaczirek, K., Soleiman, A., Schindl, M., Passler, C., Scheuba, C., Prager, G., Kaserer, K., & Niederle, B. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01158.x · Cited by 57
Hypoglycemia due to an insulin binding antibody in a patient with an IgA-κ myeloma.
Halsall, D. J., Mangi, M., Soos, M., Fahie-Wilson, M. N., Wark, G., Mainwaring-Burton, R., & O’Rahilly, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0075 · Cited by 56
Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes
Murata, G. H., Duckworth, W. C., Shah, J. H., Wendel, C. S., Mohler, M. J., & Hoffman, R. M. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.02.001 · Cited by 56
Towler, D. A., Havlin, C. E., Craft, S., et al. (1993) · Diabetes · doi:10.2337/diabetes.42.12.1791 · Cited by 56
Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes
Rossetti, P., Porcellati, F., Bolli, G. B., & Fanelli, C. G. (2008) · Diabetes Care · doi:10.2337/dc08-s227 · Cited by 55
Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses
Boyle, P. J. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.3.752 · Cited by 52
Factitial Hypoglycemia: Three Cases Diagnosed on the Basis of Insulin Antibodies
Service, F. J. (1974) · Archives of Internal Medicine · doi:10.1001/archinte.1974.00320200146022 · Cited by 51
Self-citationIs There a Place for Insulin Pump Therapy in Your Practice?
Skyler, J. S., Ponder, S., Kruger, D. F., Matheson, D., & Parkin, C. G. (2007) · Clinical Diabetes · doi:10.2337/diaclin.25.2.50 · Cited by 49
Sulfonylurea-Induced Factitious Hypoglycemia: A Growing Problem
Jordan, R. M. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.1977.03630150084023 · Cited by 47
Fukuda, M., Tanaka, A., Tahara, Y., Ikegami, H., Yamamoto, Y., Kumahara, Y., & Shima, K. (1988) · Diabetes · doi:10.2337/diabetes.37.1.81 · Cited by 47
Starke, A., Saddig, C., Kirch, B., Tschahargane, C., & Goretzki, P. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0543-6 · Cited by 46
Miraki-Moud, F., Grossman, A. B., Besser, M., Monson, J. P., & Camacho-Hübner, C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2090 · Cited by 44
Self-citationThe Diabetes Research In Children, N. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503322640971 · Cited by 44
Prevention and Correction of Hypoglycemia: Relevance to Type 1 Diabetes
Cryer, P. E. (2003) · Type 1 Diabetes · doi:10.1007/978-1-59259-310-1_7 · Cited by 42
Self-citationDiabetes and the Chronic Care Model: A Review
Warm, E. (2007) · Current Diabetes Reviews · doi:10.2174/1573399076 · Cited by 38
Horvath, K., Jeitler, K., Berghold, A., Plank, J., Pieber, T. R., & Siebenhofer, A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005613.pub2 · Cited by 38
Service, F. J., & O’Brien, P. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0033 · Cited by 34
Self-citationMassive insulin secretion in response to anaerobic exercise in exercise-induced hyperinsulinism.
Meissner, T., Friedmann, B., Okun, J. G., Schwab, M. A., Otonkoski, T., Bauer, T., Bärtsch, P., & Mayatepek, E. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-870583 · Cited by 33
Frequency of severe hypoglycaemia in type 1 and type 2 diabetes during conventional insulin therapy
Gürlek, A., Erbaş, T., & Gedik, O. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212102 · Cited by 32
Endoscopic ultrasound and neuroendocrine tumours of the pancreas.
Fritscher‐Ravens, A. (2004) · PubMed · Cited by 28
Hypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans
Heller, S. R., & Cryer, P. E. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.261.1.e41 · Cited by 26
Self-citationHyperinsulinemic hypoglycemia following gastric bypass surgery for obesity.
Goldfine, A. B., Mun, E., & Patti, M. E. (2006) · Current Opinion in Endocrinology and Diabetes · doi:10.1097/01.med.0000244222.91280.71 · Cited by 26
A glucose-responsive insulinoma.
Power, L. (1969) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1969.03150180023004 · Cited by 24
Byington, R. P., Bigger, J. T., Buse, J. B., & William, W. (2008) · Cited by 23
The Prevention and Correction of Hypoglycemia
Cryer, P. E. (2001) · Comprehensive Physiology · doi:10.1002/cphy.cp070235 · Cited by 23
Self-citationHyperinsulinaemic hypoglycaemia due to chlorpropamide-induced nesidioblastosis.
Rayman, G., Santo, M., Salomon, F., Almog, S., Paradinas, F. J., Pinkhas, J., Reynolds, K. W., & Wise, P. H. (1984) · Journal of Clinical Pathology · doi:10.1136/jcp.37.6.651 · Cited by 21
Recurrent hyperinsulinemic hypoglycemia caused by an insulin-secreting insulinoma.
Service, F. J. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0263 · Cited by 19
Self-citationHypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I
Daughaday, W. H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0378 · Cited by 18
Rizza, R. A., Haymond, M. W., Verdonk, C. A., et al. (1981) · Diabetes · doi:10.2337/diabetes.30.5.377 · Cited by 18
de Galan, B. E., Tack, C. J., Willemsen, J. J., Sweep, C. G. J. (., Smits, P., & Lenders, J. W. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031289 · Cited by 17
An unusual cause of hyperinsulinaemic hypoglycaemia syndrome.
Manning, P. J., Espiner, E. A., Yoon, K., Drury, P. L., Holdaway, I. M., & Bowers, A. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01033.x · Cited by 16
Commentary: imaging of islet-cell tumours.
Grossman, A. B., & Reznek, R. H. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.002 · Cited by 11
Self-citationFactitial hypoglycemia. Three cases diagnosed on the basis of insulin antibodies
Service, F. J. (1974) · Archives of Internal Medicine · doi:10.1001/archinte.134.2.336 · Cited by 11
Self-citation[Sulfonylurea-induced factitious hypoglycemia].
Svirski, B., & Edoute, Y. (1996) · PubMed · Cited by 7
Şimşek, Y., & Urhan, E. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103112 · Cited by 2
Research works printed but not linked: 5
- 12. Cryer P 2008 Glucose homeostasis and hypoglycemia. In: Kronenberg H, Melmed S, Polonsky K, Larsen P, eds. Williams textbook of endocrinology, 11th ed. Philadelphia: Saunders, an imprint of Elsevier, Inc.; 1503-1533
- 23. Service FJ 1987 Endocrine causes of postprandial hypoglycemia. In: An- dreani D, Marks V, Lefebvre PJ, eds. Serono Symposia. New York: Raven Press; 45-54
- 55. Hirata Y, Ishizu H, Ouchi N, Motomura S, Abe M, Hara Y, Wakasugi H, Takahashi I, Sakani H, Tanaka M, Kawano H, Kanesaka T 1970 Insulin autoimmunity in a case with spontaneous hypoglycemia. J Japan Diab Soc 13:312-320
- Gill, 2007, Exploring the ‘dead in bed syndrome’: a real life study of nocturnal hypoglycaemia, QT interval prolongation and cardiac arrhythmia, Diabet Med, 24, 13
- Ann Intern Med, 128, 165
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389
Self-citationFalconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M., Kos-Kudla, B., Kwekkeboom, D., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,362
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
“This is the standard definition in outpatients and correlates with the initial threshold for the release of counter-regulatory hormones (128, 129).”
BackgroundSelf-citationHypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128
Metadata
- Authors
- Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J.
- Affiliations
- Washington University in St. Louis (US)
- Harvard University (US)
- Queen Mary University of London (GB)
- University of Sheffield (GB)
- Mayo Clinic (V.M.M., F.J.S.), Rochester, Minnesota 55905
- University of Minnesota (US)
- Mayo Clinic (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-03-01
- Volume
- 94
- Issue
- 3
- Pages
- 709-728
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2116145810
- Cited by
- 1,277
- References
- 202
- Citations by year
- 2026: 55 · 2025: 69 · 2024: 92 · 2023: 111 · 2022: 83 · 2021: 105 · 2020: 95 · 2019: 73 · 2018: 68 · 2017: 77 · 2016: 75 · 2015: 85 · 2014: 76 · 2013: 79 · 2012: 48
- FWCI
- 20.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- hypoglycemia, diabetes mellitus, Whipple's triad, differential diagnosis of hypoglycemia, endogenous hyperinsulinism, insulin antibodies, sulfonylurea-induced hypoglycemia, drug-induced hypoglycemia, critical illness, hormone deficiency
- MeSH terms
- Adult, Diabetes Mellitus, Humans, Hypoglycemia, Risk Factors, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-27 (prompt extract-v2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.